Pasquier C - Search Results

1

HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.

Mavigner M, Delobel P, Cazabat M, Dubois M, L'faqihi-Olive FE, Raymond S, Pasquier C, Marchou B, Massip P, Izopet J. Mavigner M, et al. Among authors: pasquier c. PLoS One. 2009 Oct 30;4(10):e7658. doi: 10.1371/journal.pone.0007658. PLoS One. 2009. PMID: 19876401 Free PMC article.

2

A new generation of serum anti-HIV antibody immunocapture assay for saliva testing.

Pasquier C, Bello PY, Gourney P, Puel J, Izopet J. Pasquier C, et al. Clin Diagn Virol. 1997 Nov;8(3):195-7. doi: 10.1016/s0928-0197(97)00024-x. Clin Diagn Virol. 1997. PMID: 9406649

3

Quantification of HIV-1 proviral DNA by a standardized colorimetric PCR-based assay.

Izopet J, Tamalet C, Pasquier C, Sandres K, Marchou B, Massip P, Puel J. Izopet J, et al. Among authors: pasquier c. J Med Virol. 1998 Jan;54(1):54-9. doi: 10.1002/(sici)1096-9071(199801)54:1<54::aid-jmv8>3.0.co;2-o. J Med Virol. 1998. PMID: 9443109 Clinical Trial.

4

Molecular evidence for mother-to-child transmission of multiple variants by analysis of RNA and DNA sequences of human immunodeficiency virus type 1.

Pasquier C, Cayrou C, Blancher A, Tourne-Petheil C, Berrebi A, Tricoire J, Puel J, Izopet J. Pasquier C, et al. J Virol. 1998 Nov;72(11):8493-501. doi: 10.1128/JVI.72.11.8493-8501.1998. J Virol. 1998. PMID: 9765386 Free PMC article.

5

Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapy.

Segondy M, Izopet J, Pellegrin I, Montes B, Dumon B, Pasquier C, Peeters M, Fleury HJ, Puel J, Reynes J. Segondy M, et al. Among authors: pasquier c. J Clin Microbiol. 1998 Nov;36(11):3392-5. doi: 10.1128/JCM.36.11.3392-3395.1998. J Clin Microbiol. 1998. PMID: 9774604 Free PMC article.

6

Assessment of a hepatitis C virus antibody assay in saliva for epidemiological studies.

Bello PY, Pasquier C, Gourney P, Puel J, Izopet J. Bello PY, et al. Among authors: pasquier c. Eur J Clin Microbiol Infect Dis. 1998 Aug;17(8):570-2. doi: 10.1007/BF01708621. Eur J Clin Microbiol Infect Dis. 1998. PMID: 9796656

7

Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy.

Izopet J, Salama G, Pasquier C, Sandres K, Marchou B, Massip P, Puel J. Izopet J, et al. Among authors: pasquier c. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15;19(5):478-83. doi: 10.1097/00042560-199812150-00006. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9859961

8

Intermittent selection pressure with zidovudine plus zalcitabine treatment reduces the emergence in vivo of zidovudine resistance HIV mutations.

Izopet J, Sailler L, Sandres K, Pasquier C, Bonnet E, Aquilina C, Puel J, Massip P, Marchou B. Izopet J, et al. Among authors: pasquier c. J Med Virol. 1999 Feb;57(2):163-8. J Med Virol. 1999. PMID: 9892402 Clinical Trial.

9

Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit.

Izopet J, Pasquier C, Sandres K, Puel J, Rostaing L. Izopet J, et al. Among authors: pasquier c. J Med Virol. 1999 Jun;58(2):139-44. doi: 10.1002/(sici)1096-9071(199906)58:2<139::aid-jmv7>3.0.co;2-7. J Med Virol. 1999. PMID: 10335861

10

Using RT-PCR and bDNA assays to measure non-clade B HIV-1 subtype RNA.

Pasquier C, Sandres K, Salama G, Puel J, Izopet J. Pasquier C, et al. J Virol Methods. 1999 Aug;81(1-2):123-9. doi: 10.1016/s0166-0934(99)00057-9. J Virol Methods. 1999. PMID: 10488770

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters